Serum Ghrelin in Polycystic Ovary Syndrome

Ghrelin in Polycystic Ovary Syndrome

Status

UNKNOWN

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT02087410

Enrollment

Registered

2014-03-14

Start date

2014-04-30

Completion date

2014-12-31

Last updated

2014-03-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Polycystic Ovary

Brief summary

measuring serum gherlin in polycystic ovary syndrome patients and compare it to healthy levels

Detailed description

two groups one healthy and other with pco measure ghrelin level in both of them to find relation between pco and ghrelin

Interventions

None listed

Study design

Observational model

CASE_CONTROL

Time perspective

CROSS_SECTIONAL

Eligibility

Sex/Gender

FEMALE

Age

20 Years to 35 Years

Healthy volunteers

Yes

Inclusion criteria

pco women * At least 12 months of infertility. * Patients with polycystic ovarian syndrome according to Rotterdam criteria:

Exclusion criteria

* Patients with hyperprolactinemia * Patients with Cushing's syndrome * Patients with Congenital or non-classical adrenal hyperplasia * Patients with hormone secreting tumors. * Patients with hormonal treatment in the last 3 months.

Design outcomes

Primary

Measure	Time frame	Description
relationships between circulating ghrelin and the clinical and biochemical manifestations of PCOS	after 6 monthes	Analysis of levels of ghrelin in study group

Countries

Egypt

Outcome results